Plain-English translation of NCT05746182 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at UC San Francisco want to understand why some people develop pancreatic neuroendocrine tumors by looking for inherited genetic changes. This study will ask eligible participants to provide a blood or saliva sample for genetic testing using a comprehensive panel that examines over 80 genes linked to cancer risk. The findings may help doctors better understand your tumor and identify whether other family members should be screened.
Many cancers run in families because of inherited genetic mutations, but we don't yet know how common these mutations are in people with pancreatic neuroendocrine tumors. By studying the genetics of a large group of patients, researchers hope to identify patterns that could improve screening, early detection, and treatment decisions for you and your relatives.
You likely qualify if…
You likely don't qualify if…
If you join, you will first watch an informational video about genetic testing to help you make an informed decision. You'll then provide a blood or saliva sample for the genetic test. The study team will share your results with you and your doctor, and you'll be asked to complete a short survey about your thoughts on the testing process. The entire process typically takes place over one or two clinic visits.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
United States